Lixin Li

Lixin Li is a Professor at the Physician Assistant Program within the College of Medicine at Central Michigan University. Her research focuses on the molecular mechanisms of type 2 diabetes, β-cell dysfunction, obesity-associated insulin resistance, and the role of GLP-1 agonists like liraglutide in metabolic and neurodegenerative diseases.

• Education: MD from Southeast University, PhD from Norwegian University of Science and Technology

Dr. Li's research spans diabetes pathogenesis, glucagon-like peptide-1 (GLP-1) signaling, and the intersection of metabolic disorders with neurodegenerative conditions such as Alzheimer's. Her work explores how GLP-1 agonists like liraglutide offer cytoprotective effects, reduce inflammation, and influence microRNA pathways in obesity and diabetes.

The 15 most recent articles highlight her contributions to diabetes research (β-cell biology, GLP-1 mechanisms), obesity management (liraglutide, berberine), and neurodegenerative disease prevention. Key subfields include endocrinology, pharmacology, molecular biology, and medical education innovations.

• Scientific Awards:
  • Timeposters Award
  • Williams S. Fenwick Fellowship
  • Chisholm Memorial Fellowship
  • Postdoctoral Fellowships: Canadian Diabetes Association, Banting and Best Diabetes Centre
  • Trainee Travel Award, Banting and Best Diabetes Centre

Dr. Li has mentored in physician assistant education and delivered invited talks globally on diabetes, obesity, and GLP-1 agonists. She holds memberships in professional societies including the American Diabetes Association and American Physiology Association.